PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 5, 2026BMC Ophthalmology0 citationsOpen Access

Bilateral idiopathic peripapillary choroidal neovascularization in a child with bruton disease: a case report

SKSarah KerkouriJDJ. Le DinahetMBM. Bourhis

Key Points

  • To describe a rare case of bilateral peripapillary choroidal neovascularization in a child with Bruton disease.
  • Case report of a 13-year-old boy with XLA presenting with vision loss.
  • Comprehensive imaging including fundus exam and multimodal imaging confirmed PPCNV.
  • Extensive immunologic and infectious tests were performed, including MRI and broad serology panels.
  • Treatment involved intravitreal aflibercept leading to short-term improvement.
  • Initial improvement in vision and anatomy after treatment with intravitreal aflibercept.
  • Subsequent development of macular atrophy with limited visual recovery.
  • No underlying ocular inflammation or congenital anomalies identified.

Abstract

To describe a rare, unexplained case of bilateral peripapillary choroidal neovascularization (PPCNV) in a child with X-linked agammaglobulinemia (XLA, Bruton disease). A 13-year-old boy with XLA on regular intravenous immunoglobulin replacement presented with rapidly progressive bilateral vision loss. Best-corrected visual acuity (BCVA) was 20/100 OU. Fundus exam and multimodal imaging confirmed bilateral PPCNV with subretinal fluid. Extensive systemic, infectious, and immunologic investigations, including MRI, CT, cerebrospinal fluid, and broad serology panels, were unrevealing; interpretation of serologies was confounded by IVIG therapy. Intravitreal aflibercept led to initial anatomical and functional improvement, but macular atrophy subsequently developed, with limited visual recovery. No ocular inflammation or congenital optic disc anomaly was identified. Pediatric PPCNV is rare and usually secondary to inflammation or congenital anomalies. To our knowledge, this is the first report of PPCNV in XLA. Although the association appears coincidental, collaborative reporting of similar cases is needed to explore possible immunologic contributions and refine treatment strategies.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Kerkouri et al. (2026) studied this question.

synapsesocial.com/papers/69a91dedd6127c7a504c13f1https://doi.org/10.1186/s12886-026-04691-2
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Choroidal neovascularisation secondary toX-linked retinoschisis2024 · 5 citations
  2. 2PHOTODYNAMIC THERAPY FOR CHOROIDAL NEOVASCULARIZATION IN PEDIATRIC PATIENTS2005 · 41 citations
  3. 3Peripapillary Choroidal Thickness Variation With Age and Race in Normal Eyes2015 · 66 citations
  4. 4VERTEPORFIN PHOTODYNAMIC THERAPY INVOLVING THE OPTIC NERVE FOR PERIPAPILLARY CHOROIDAL NEOVASCULARIZATION2008 · 26 citations
  5. 5Choroidal Neovascularization2017 · 27 citations